Cargando…
PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431704/ http://dx.doi.org/10.1097/01.HS9.0000850360.32912.a6 |
| _version_ | 1784780128482492416 |
|---|---|
| author | Gaitonde, P. Liljas, B. Shaw, B. Miranda, P. |
| author_facet | Gaitonde, P. Liljas, B. Shaw, B. Miranda, P. |
| author_sort | Gaitonde, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431704 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94317042022-08-31 PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA Gaitonde, P. Liljas, B. Shaw, B. Miranda, P. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431704/ http://dx.doi.org/10.1097/01.HS9.0000850360.32912.a6 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Gaitonde, P. Liljas, B. Shaw, B. Miranda, P. PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title | PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full | PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_fullStr | PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_full_unstemmed | PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_short | PB1877: ADJUSTING SURVIVAL DATA FOR TREATMENT CROSSOVER IN THE ELEVATE-TN TRIAL BY USING A HISTORICAL COHORT OF PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY IN FRONT-LINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| title_sort | pb1877: adjusting survival data for treatment crossover in the elevate-tn trial by using a historical cohort of patients treated with chemoimmunotherapy in front-line chronic lymphocytic leukemia |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431704/ http://dx.doi.org/10.1097/01.HS9.0000850360.32912.a6 |
| work_keys_str_mv | AT gaitondep pb1877adjustingsurvivaldatafortreatmentcrossoverintheelevatetntrialbyusingahistoricalcohortofpatientstreatedwithchemoimmunotherapyinfrontlinechroniclymphocyticleukemia AT liljasb pb1877adjustingsurvivaldatafortreatmentcrossoverintheelevatetntrialbyusingahistoricalcohortofpatientstreatedwithchemoimmunotherapyinfrontlinechroniclymphocyticleukemia AT shawb pb1877adjustingsurvivaldatafortreatmentcrossoverintheelevatetntrialbyusingahistoricalcohortofpatientstreatedwithchemoimmunotherapyinfrontlinechroniclymphocyticleukemia AT mirandap pb1877adjustingsurvivaldatafortreatmentcrossoverintheelevatetntrialbyusingahistoricalcohortofpatientstreatedwithchemoimmunotherapyinfrontlinechroniclymphocyticleukemia |